Samir M. Deshpande - 15 Dec 2024 Form 4 Insider Report for HUMANA INC (HUM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Dec 2024, 13:43:34 UTC
Prior SEC filing
23 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Samir M. Deshpande

Key filing fact

Samir M. Deshpande filed Form 4 for HUMANA INC (HUM) on 17 Dec 2024.

Key facts

  • This page summarizes Samir M. Deshpande's Form 4 filing for HUMANA INC (HUM).
  • 7 reported transactions and 7 derivative rows are listed below.
  • Accepted by SEC: 17 Dec 2024, 13:43.

Change

  • Previous filing in this sequence was filed on 23 Feb 2024.
  • Current net transaction value: -$144,803.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HUM transaction

Humana Common

Tax liability

Transaction value
$60,040
Shares
-221
Change %
-1.6%
Price
$271.68
Shares after
13,639
Date
15 Dec 2024
Ownership
Direct
Footnotes
F9
HUM transaction

Humana Common

Options Exercise

Transaction value
$0
Shares
+353
Change %
+2.6%
Price
$0.000000
Shares after
13,992
Date
15 Dec 2024
Ownership
Direct
HUM transaction

Humana Common

Tax liability

Transaction value
$43,468
Shares
-160
Change %
-1.1%
Price
$271.68
Shares after
13,832
Date
15 Dec 2024
Ownership
Direct
Footnotes
F9
HUM transaction

Humana Common

Options Exercise

Transaction value
$0
Shares
+335
Change %
+2.4%
Price
$0.000000
Shares after
14,167
Date
15 Dec 2024
Ownership
Direct
HUM transaction

Humana Common

Tax liability

Transaction value
$41,295
Shares
-152
Change %
-1.1%
Price
$271.68
Shares after
14,015
Date
15 Dec 2024
Ownership
Direct
Footnotes
F9, F10

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HUM transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-353
Change %
-100%
Price
$0.000000
Shares after
0
Date
15 Dec 2024
Ownership
Direct
Underlying class
Humana Common
Underlying amount
353
Exercise price
Footnotes
F6, F7
HUM transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-335
Change %
-50%
Price
$0.000000
Shares after
335
Date
15 Dec 2024
Ownership
Direct
Underlying class
Humana Common
Underlying amount
335
Exercise price
Footnotes
F6, F8
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,730
Date
15 Dec 2024
Ownership
Direct
Underlying class
Humana Common
Underlying amount
5,730
Exercise price
$350.79
Footnotes
F1
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,327
Date
15 Dec 2024
Ownership
Direct
Underlying class
Humana Common
Underlying amount
4,327
Exercise price
$376.61
Footnotes
F2
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,836
Date
15 Dec 2024
Ownership
Direct
Underlying class
Humana Common
Underlying amount
3,836
Exercise price
$425.06
Footnotes
F3
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,878
Date
15 Dec 2024
Ownership
Direct
Underlying class
Humana Common
Underlying amount
3,878
Exercise price
$510.24
Footnotes
F4
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,652
Date
15 Dec 2024
Ownership
Direct
Underlying class
Humana Common
Underlying amount
5,652
Exercise price
$367.21
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.

Footnote F2

Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.

Footnote F3

Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.

Footnote F4

Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.

Footnote F5

Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

Footnote F6

Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

Footnote F7

Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

Footnote F8

Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

Footnote F9

Shares disposed of represent payment for tax liability on restricted stock units vested on 12/15/24.

Footnote F10

Includes 976 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .